[13C,2H5]-Dolutegravir

Catalog Number	ACMA00065406
Description	Dolutegravir is intended for Pharmaceuticals applications. Phase III clinical trials for the treatment of HIV infection. All information about [13C,2H5]-Dolutegravir is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis.
Molecular Weight	425.33
Molecular Formula	C20H19F2N3O5
Purity	≥95%
Isotopic Enrichment	99% 13C, 98% 2H
Stability	≥1 year
Unlabeled CAS	1051375-16-6

Please kindly note that our products and services are for research use only.

Online Inquiry



mg g kg ml L

[13C,2H5]-Dolutegravir (ACMA00065406)

SUBMIT